Seelos Therapeutics, Inc.

UBS Group AG

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/9/2023

Shares

2,226

Value ($000)

0

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/9/2023	0	0.0%	2,226	9/30/2023
2023 Q2	8/11/2023	3	0.0%	2,298	6/30/2023
2023 Q1	5/12/2023	2	0.0%	2,226	3/31/2023
2022 Q4	2/8/2023	7	0.0%	9,743	12/31/2022
2022 Q3	11/10/2022	24	0.0%	23,585	9/30/2022
2022 Q2	8/10/2022	2	0.0%	2,226	6/30/2022
2022 Q1	5/16/2022	3	0.0%	3,703	3/31/2022
2021 Q4	2/14/2022	70	0.0%	43,540	12/31/2021
2021 Q3	11/15/2021	7	0.0%	3,039	9/30/2021
2021 Q2	8/13/2021	0	0.0%	39	6/30/2021
2021 Q1	5/12/2021	43	0.0%	8,627	3/31/2021
2020 Q4	2/11/2021	0	0.0%	39	12/31/2020
2020 Q3	11/12/2020	0	0.0%	37	9/30/2020
2020 Q2	7/31/2020	4	0.0%	3,678	6/30/2020
2020 Q1	5/1/2020	6	0.0%	12,650	3/31/2020
2019 Q4	2/14/2020	0	0.0%	1	12/31/2019